CymaBay Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
CymaBay Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q4 2023.
  • CymaBay Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending December 31, 2023 was $4.8M, a 2741% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $4.8M +$4.63M +2741% Dec 31, 2023 10-K 2024-02-28
Q3 2023 $57K -$140K -71.1% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $99K -$121K -55% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $137K -$102K -42.7% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $169K -$85K -33.5% Dec 31, 2022 10-Q 2023-11-07
Q3 2022 $197K -$67K -25.4% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $220K -$50K -18.5% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $239K -$34K -12.5% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $254K -$18K -6.62% Dec 31, 2021 10-K 2023-03-23
Q3 2021 $264K -$4K -1.49% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $270K +$10K +3.85% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $273K +$24K +9.64% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 $272K +$37K +15.7% Dec 31, 2020 10-K 2022-03-17
Q3 2020 $268K +$49K +22.4% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $260K +$61K +30.7% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $249K +$72K +40.7% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 $235K Dec 31, 2019 10-K 2021-03-25
Q3 2019 $219K Sep 30, 2019 10-Q 2019-11-05
Q2 2019 $199K Jun 30, 2019 10-Q 2019-08-07
Q1 2019 $177K Mar 31, 2019 10-Q 2019-05-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.